Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Adaptive Symbiotic Technologies
AddedFeb 16, 2024
UpdatedJun 18, 2026
Adaptive Symbiotic Technologies

Adaptive Symbiotic Technologies

Series A

Seattle-based biotech firm specializing in symbiotic plant microbes for enhanced crop yield.

HQ
Seattle, WA, US
Founded
2011
Overview
Compare
Fundraising
Employees

Adaptive Symbiotic Technologies is a Seattle-based agricultural biotech company specializing in the research and production of symbiotic plant microbes. These microbes enhance crop yield by enabling plants to tolerate environmental stresses, offering innovative solutions for farmers to improve agricultural productivity.

The company has made significant strides in the biotech industry, contributing to sustainable farming practices. Its innovative products have positively impacted crop resilience and yield, benefiting farmers and advancing agricultural technology.

Adaptive Symbiotic Technologies - Similar Companies

Intrinsyx Bio logo

Intrinsyx Bio

intrinsyxbio.com

AgBiome logo

AgBiome

agbiome.com

Agradis logo

Agradis

Omnicrobe logo

Omnicrobe

Ascribe Bioscience logo

Ascribe Bioscience

ascribebio.com

BioConsortia logo

BioConsortia

bioconsortia.com

NewLeaf Symbiotics logo

NewLeaf Symbiotics

newleafsym.com

Pivot Bio logo

Pivot Bio

pivotbio.com

Growcentia logo

Growcentia

growcentia.com

Targeted Growth logo

Targeted Growth

EvoAktiv logo

EvoAktiv

evoagtec.com

Advanced Biological Marketing logo

Advanced Biological Marketing

Montana BioAgriculture logo

Montana BioAgriculture

montanabioag.com

Lytos Technologies logo

Lytos Technologies

lytostech.com

Botanisol Analytics logo

Botanisol Analytics

Adaptive Symbiotic Technologies - Quick Facts

Who are Adaptive Symbiotic Technologies' competitors?

Companies similar to Adaptive Symbiotic Technologies include Intrinsyx Bio, AgBiome, Agradis and Omnicrobe.

When was Adaptive Symbiotic Technologies founded?

Adaptive Symbiotic Technologies was founded in 2011.

Where is Adaptive Symbiotic Technologies' headquarters located?

Adaptive Symbiotic Technologies' headquarters is located in Seattle, WA, US.

When was Adaptive Symbiotic Technologies' last funding round?

Adaptive Symbiotic Technologies' most recent funding round was for $3.4M (USD) in January 2016.

How much has Adaptive Symbiotic Technologies raised to-date?

As of Jan 21, 2016, Adaptive Symbiotic Technologies has raised a total of $4.5M (USD).

How many employees does Adaptive Symbiotic Technologies have?

Adaptive Symbiotic Technologies has 17 employees as of Feb 5, 2024.

Adaptive Symbiotic Technologies - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Agricultural Products
Tags
  • AgTech
  • eCommerce
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified